Latest News & Features
Generics
Pfizer subsidiary Anacor has filed five lawsuits targeting drug manufacturers looking to manufacture generic versions of its eczema treatment Eucrisa. 28 September 2021
Biotechnology
Over the past year, the life sciences sector has proved to be of vital importance in the fight against COVID-19. Now more than ever, it is imperative that IP professionals are best positioned to protect and leverage innovation in this fast-paced industry. 28 September 2021
Americas
Law firm Cozen O’Connor has hired patent counsellor Todd Buck to lead trade secret proceedings at its IP and business law practices in Washington DC. 24 September 2021
Americas
The US Patent Trial and Appeal Board has confirmed the validity of three remaining Medtronic patents challenged by rival medical device manufacturer Axonics. 23 September 2021
Americas
Mexico’s updated IP laws seek to avoid the patentability of plants obtained by essentially biological processes—creating issues for plant rights owners, explains Corina Silva of Uhthoff, Gómez Vega & Uhthoff. 23 September 2021
Big Pharma
Dietary supplements company Elysium Health has convinced a Delaware court to invalidate two vitamin B3 patents belonging to rival ChromaDex and Dartmouth College. 23 September 2021
Americas
Former Food and Drug Administration Chief Counsel Stacy Cline Amin has been hired as a partner at Morrison & Foerster’s life sciences and healthcare practice in Washington DC. 22 September 2021
Generics
Veterinary drug maker Dechra’s generic of a drug that treats vomiting in dogs and cats, Cerenia, infringes a patent owned by its competitor Zoetis, a new lawsuit has alleged. 21 September 2021
Generics
Several US lawmakers have called upon the US Patent and Trademark Office to curb the increase in inter partes review denials to combat the “soaring cost” of prescription drugs. 21 September 2021
Americas
Supernus Pharmaceuticals has once again accused Indian generic drugmaker Zydus Cadila and its US unit of allegedly infringing 10 patents with its copycat of Trokendi XR (topiramate), a drug for migraines and seizures. 20 September 2021